From AI to VR, and everything in between—explore the cutting-edge tools revolutionizing medical training. Learn why these advancements are crucial for maintaining standards and excelling in the ...

The UK-wide Innovative Licensing and Access Pathway (ILAP) was first launched in 2021 to reduce the time to market for innovative medicines by offering drug developers a single platform to collaborate ...

Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

If 2024 saw an unparalleled acceleration in the wider public’s awareness of AI, then 2025 will be the year when its practical application becomes mainstream.